scispace - formally typeset
Search or ask a question
Institution

Tehran University of Medical Sciences

EducationTehran, Iran
About: Tehran University of Medical Sciences is a education organization based out in Tehran, Iran. It is known for research contribution in the topics: Population & Medicine. The organization has 35661 authors who have published 57234 publications receiving 878523 citations. The organization is also known as: TUMS.


Papers
More filters
Journal ArticleDOI
TL;DR: The nutrition transition in Iran is occurring rapidly, secondary to the rapid change in fertility and mortality patterns and to urbanisation, and is occurring against the backdrop of lack of sustained economicgrowth.
Abstract: Objective: To describe the emergence of the nutrition transition, and associated morbidity shifts, in the Islamic Republic of Iran. Design: Review and analysis of secondary data relating to the socio-political and nutritional context, demographic trends, food utilisation and consumption patterns, obesity, and diet-related morbidity. Results and conclusions: The nutrition transition in Iran is occurring rapidly, secondary to the rapid change in fertility and mortality patterns and to urbanisation. The transition is occurring against the backdrop of lack of sustained economic growth. There is considerable imbalance in food consumption with low nutrient density characterising diets at all income levels, over-consumption evident among more than a third of households, and food insecurity among 20% of the population. Obesity is an emerging problem, particularly in urban areas and for women, and both diabetes and other risk factors for heart disease are becoming significant problems.

479 citations

Journal ArticleDOI
Daniel E. Neafsey1, Robert M. Waterhouse, Mohammad Reza Abai2, Sergey Aganezov3, Max A. Alekseyev3, James E. Allen4, James Amon, Bruno Arcà5, Peter Arensburger6, Gleb N. Artemov7, Lauren A. Assour8, Hamidreza Basseri2, Aaron M. Berlin1, Bruce W. Birren1, Stéphanie Blandin9, Stéphanie Blandin10, Andrew I. Brockman11, Thomas R. Burkot12, Austin Burt11, Clara S. Chan13, Cedric Chauve14, Joanna C. Chiu15, Mikkel B. Christensen4, Carlo Costantini16, Victoria L.M. Davidson17, Elena Deligianni18, Tania Dottorini11, Vicky Dritsou19, Stacey Gabriel1, Wamdaogo M. Guelbeogo, Andrew Brantley Hall20, Mira V. Han21, Thaung Hlaing, Daniel S.T. Hughes4, Daniel S.T. Hughes22, Adam M. Jenkins23, Xiaofang Jiang20, Irwin Jungreis13, Evdoxia G. Kakani24, Evdoxia G. Kakani19, Maryam Kamali20, Petri Kemppainen25, Ryan C. Kennedy26, Ioannis K. Kirmitzoglou11, Ioannis K. Kirmitzoglou27, Lizette L. Koekemoer28, Njoroge Laban, Nicholas Langridge4, Mara K. N. Lawniczak11, Manolis Lirakis29, Neil F. Lobo8, Ernesto Lowy4, Robert M. MacCallum11, Chunhong Mao20, Gareth Maslen4, Charles Mbogo30, Jenny McCarthy6, Kristin Michel17, Sara N. Mitchell24, Wendy Moore31, Katherine A. Murphy15, Anastasia N. Naumenko20, Tony Nolan11, Eva Maria Novoa13, Samantha M. O’Loughlin11, Chioma Oringanje31, Mohammad Ali Oshaghi2, Nazzy Pakpour15, Philippos Aris Papathanos11, Philippos Aris Papathanos19, Ashley Peery20, Michael Povelones32, Anil Prakash33, David P. Price34, Ashok Rajaraman14, Lisa J. Reimer35, David C. Rinker36, Antonis Rokas37, Tanya L. Russell12, N’Fale Sagnon, Maria V. Sharakhova20, Terrance Shea1, Felipe A. Simão38, Felipe A. Simão39, Frédéric Simard16, Michel A. Slotman40, Pradya Somboon41, V. N. Stegniy7, Claudio J. Struchiner42, Claudio J. Struchiner43, Gregg W.C. Thomas44, Marta Tojo45, Pantelis Topalis18, Jose M. C. Tubio46, Maria F. Unger8, John Vontas29, Catherine Walton25, Craig S. Wilding47, Judith H. Willis48, Yi-Chieh Wu49, Yi-Chieh Wu13, Guiyun Yan50, Evgeny M. Zdobnov38, Evgeny M. Zdobnov39, Xiaofan Zhou37, Flaminia Catteruccia19, Flaminia Catteruccia24, George K. Christophides11, Frank H. Collins8, Robert S. Cornman48, Andrea Crisanti11, Andrea Crisanti19, Martin J. Donnelly35, Martin J. Donnelly46, Scott J. Emrich8, Michael C. Fontaine8, Michael C. Fontaine51, William M. Gelbart24, Matthew W. Hahn44, Immo A. Hansen34, Paul I. Howell52, Fotis C. Kafatos11, Manolis Kellis13, Daniel Lawson4, Christos Louis18, Shirley Luckhart15, Marc A. T. Muskavitch23, Marc A. T. Muskavitch53, José M. C. Ribeiro, Michael A. Riehle31, Igor V. Sharakhov20, Zhijian Tu20, Laurence J. Zwiebel37, Nora J. Besansky8 
Broad Institute1, Tehran University of Medical Sciences2, George Washington University3, European Bioinformatics Institute4, Sapienza University of Rome5, Temple University6, Tomsk State University7, University of Notre Dame8, Centre national de la recherche scientifique9, French Institute of Health and Medical Research10, Imperial College London11, James Cook University12, Massachusetts Institute of Technology13, Simon Fraser University14, University of California, Davis15, Institut de recherche pour le développement16, Kansas State University17, Foundation for Research & Technology – Hellas18, University of Perugia19, Virginia Tech20, University of Nevada, Las Vegas21, Baylor College of Medicine22, Boston College23, Harvard University24, University of Manchester25, University of California, San Francisco26, University of Cyprus27, National Health Laboratory Service28, University of Crete29, Kenya Medical Research Institute30, University of Arizona31, University of Pennsylvania32, Indian Council of Medical Research33, New Mexico State University34, Liverpool School of Tropical Medicine35, Vanderbilt University Medical Center36, Vanderbilt University37, University of Geneva38, Swiss Institute of Bioinformatics39, Texas A&M University40, Chiang Mai University41, Oswaldo Cruz Foundation42, Rio de Janeiro State University43, Indiana University44, University of Santiago de Compostela45, Wellcome Trust Sanger Institute46, Liverpool John Moores University47, University of Georgia48, Harvey Mudd College49, University of California, Irvine50, University of Groningen51, Centers for Disease Control and Prevention52, Biogen Idec53
02 Jan 2015-Science
TL;DR: The authors investigated the genomic basis of vectorial capacity and explore new avenues for vector control, sequenced the genomes of 16 anopheline mosquito species from diverse locations spanning ~100 million years of evolution Comparative analyses show faster rates of gene gain and loss, elevated gene shuffling on the X chromosome, and more intron losses, relative to Drosophila.
Abstract: Variation in vectorial capacity for human malaria among Anopheles mosquito species is determined by many factors, including behavior, immunity, and life history To investigate the genomic basis of vectorial capacity and explore new avenues for vector control, we sequenced the genomes of 16 anopheline mosquito species from diverse locations spanning ~100 million years of evolution Comparative analyses show faster rates of gene gain and loss, elevated gene shuffling on the X chromosome, and more intron losses, relative to Drosophila Some determinants of vectorial capacity, such as chemosensory genes, do not show elevated turnover but instead diversify through protein-sequence changes This dynamism of anopheline genes and genomes may contribute to their flexible capacity to take advantage of new ecological niches, including adapting to humans as primary hosts

476 citations

Journal ArticleDOI
Heather Orpana1, Heather Orpana2, Laurie B. Marczak3, Megha Arora3  +338 moreInstitutions (173)
06 Feb 2019-BMJ
TL;DR: Age standardised mortality rates for suicide have greatly reduced since 1990, but suicide remains an important contributor to mortality worldwide and can be targeted towards vulnerable populations if they are informed by variations in mortality rates.
Abstract: Objectives To use the estimates from the Global Burden of Disease Study 2016 to describe patterns of suicide mortality globally, regionally, and for 195 countries and territories by age, sex, and Socio-demographic index, and to describe temporal trends between 1990 and 2016. Design Systematic analysis. Main outcome measures Crude and age standardised rates from suicide mortality and years of life lost were compared across regions and countries, and by age, sex, and Socio-demographic index (a composite measure of fertility, income, and education). Results The total number of deaths from suicide increased by 6.7% (95% uncertainty interval 0.4% to 15.6%) globally over the 27 year study period to 817 000 (762 000 to 884 000) deaths in 2016. However, the age standardised mortality rate for suicide decreased by 32.7% (27.2% to 36.6%) worldwide between 1990 and 2016, similar to the decline in the global age standardised mortality rate of 30.6%. Suicide was the leading cause of age standardised years of life lost in the Global Burden of Disease region of high income Asia Pacific and was among the top 10 leading causes in eastern Europe, central Europe, western Europe, central Asia, Australasia, southern Latin America, and high income North America. Rates for men were higher than for women across regions, countries, and age groups, except for the 15 to 19 age group. There was variation in the female to male ratio, with higher ratios at lower levels of Socio-demographic index. Women experienced greater decreases in mortality rates (49.0%, 95% uncertainty interval 42.6% to 54.6%) than men (23.8%, 15.6% to 32.7%). Conclusions Age standardised mortality rates for suicide have greatly reduced since 1990, but suicide remains an important contributor to mortality worldwide. Suicide mortality was variable across locations, between sexes, and between age groups. Suicide prevention strategies can be targeted towards vulnerable populations if they are informed by variations in mortality rates.

472 citations

Journal ArticleDOI
A. Sibley, Kwang Hyub Han1, A. Abourached, Laurentius A. Lesmana2, Mihály Makara, Wasim Jafri3, Riina Salupere4, Abdullah M. Assiri, Adrian Goldis, Faisal Abaalkhail5, Zaigham Abbas6, A. Abdou7, F. Al Braiki, F. Al Hosani, K. Al Jaberi, M. Al Khatry, M. A. Al Mulla, H. Al Quraishi7, A. Al Rifai, Y. Al Serkal, Altaf Alam8, Seyed Moayed Alavian9, Hamad I. Al-Ashgar5, S. Alawadhi7, L. Al-Dabal7, P. Aldins, Faleh Z. Al-Faleh10, Abdullah S. Alghamdi, R. Al-Hakeem, Abdulrahman Aljumah11, A. Almessabi, Adel Alqutub, Khalid Alswat10, Ibrahim Altraif11, M. Alzaabi, N. Andrea, Mohamed A. Babatin, A. Baqir, M. T. Barakat, Ottar M. Bergmann, Abdul Rahman Bizri12, Sarah Blach, Asad Chaudhry, M. S. Choi13, T. Diab, Samsuridjal Djauzi2, E. S. El Hassan7, S. El Khoury14, Chris Estes, S. Fakhry, J. I. Farooqi15, J. I. Farooqi16, H. Fridjonsdottir17, Rino Alvani Gani2, A. Ghafoor Khan16, Liana Gheorghe, Magnus Gottfredsson18, S. Gregorcic19, Jessie Gunter, Behzad Hajarizadeh20, Behzad Hajarizadeh21, Saeed Hamid3, Irsan Hasan2, Almoutaz Hashim5, Gabor Horvath, Béla Hunyady22, R. Husni23, Agita Jeruma, Jon G. Jonasson17, Jon G. Jonasson24, B. Karlsdottir, Do Young Kim1, Young Seok Kim25, Z. Koutoubi26, Valentina Liakina27, Valentina Liakina28, Young-Suk Lim29, A. Löve24, A. Löve18, Matti Maimets4, Reza Malekzadeh30, Mojca Maticic19, Muhammad S. Memon31, Shahin Merat30, Jacques E Mokhbat23, Fadi H. Mourad12, David H. Muljono32, David H. Muljono33, Arif Nawaz34, N. Nugrahini, S. Olafsson, S. Priohutomo, H. Qureshi35, P. Rassam14, Homie Razavi, Devin Razavi-Shearer, Kathryn Razavi-Shearer, Baiba Rozentale, M. Sadik31, K. Saeed, A. Salamat36, Faisal M. Sanai10, A. Sanityoso Sulaiman2, R. A. Sayegh37, Ala I. Sharara12, M. Siddiq34, A. M. Siddiqui38, G. Sigmundsdottir, B. Sigurdardottir, Danute Speiciene28, Andri Sanityoso Sulaiman2, Marwa Sultan, M. Taha, Junko Tanaka39, H. Tarifi, G. Tayyab40, Ieva Tolmane, M. Ud Din, M. Umar2, M. Umar41, M. Umar42, Jonas Valantinas28, J. Videčnik-Zorman19, Cesar Yaghi37, Evy Yunihastuti2, M. A. Yusuf34, Bader Faiyaz Zuberi43, Jonathan Schmelzer 
TL;DR: The current treatment rate and efficacy are not sufficient to manage the disease burden of hepatitis C virus and alternative strategies are required to keep the number of HCV individuals with advanced liver disease and liver‐related deaths from increasing.
Abstract: The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population ages. A modelling approach was used to estimate the total number of viremic infections, diagnosed, treated and new infections in 2013. In addition, the model was used to estimate the change in the total number of HCV infections, the disease progression and mortality in 2013-2030. Finally, expert panel consensus was used to capture current treatment practices in each country. Using today's treatment paradigm, the total number of HCV infections is projected to decline or remain flat in all countries studied. However, in the same time period, the number of individuals with late-stage liver disease is projected to increase. This study concluded that the current treatment rate and efficacy are not sufficient to manage the disease burden of HCV. Thus, alternative strategies are required to keep the number of HCV individuals with advanced liver disease and liver-related deaths from increasing.

463 citations

Journal ArticleDOI
TL;DR: A huge body of evidence exists on the possible role of pesticide exposures in the elevated incidence of human diseases such as cancers, Alzheimer, Parkinson, amyotrophic lateral sclerosis, asthma, bronchitis, infertility, birth defects, attention deficit hyperactivity disorder, autism, diabetes, and obesity.
Abstract: Pesticides are a family of compounds which have brought many benefits to mankind in the agricultural, industrial, and health areas, but their toxicities in both humans and animals have always been a concern. Regardless of acute poisonings which are common for some classes of pesticides like organophosphoruses, the association of chronic and sub-lethal exposure to pesticides with a prevalence of some persistent diseases is going to be a phenomenon to which global attention has been attracted. In this review, incidence of various malignant, neurodegenerative, respiratory, reproductive, developmental, and metabolic diseases in relation to different routes of human exposure to pesticides such as occupational, environmental, residential, parental, maternal, and paternal has been systematically criticized in different categories of pesticide toxicities like carcinogenicity, neurotoxicity, pulmonotoxicity, reproductive toxicity, developmental toxicity, and metabolic toxicity. A huge body of evidence exists on the possible role of pesticide exposures in the elevated incidence of human diseases such as cancers, Alzheimer, Parkinson, amyotrophic lateral sclerosis, asthma, bronchitis, infertility, birth defects, attention deficit hyperactivity disorder, autism, diabetes, and obesity. Most of the disorders are induced by insecticides and herbicides most notably organophosphorus, organochlorines, phenoxyacetic acids, and triazine compounds.

457 citations


Authors

Showing all 35946 results

NameH-indexPapersCitations
Graeme J. Hankey137844143373
Paul D.P. Pharoah13079471338
Jerome Ritz12064447987
Reza Malekzadeh118900139272
Robert N. Weinreb117112459101
Javad Parvizi11196951075
Omid C. Farokhzad11032964226
Ali Mohammadi106114954596
Alexander R. Vaccaro102117939346
John R. Speakman9566734484
Philip J. Devereaux94443110428
Rafael Lozano94265126513
Mohammad Abdollahi90104535531
Ingmar Skoog8945828998
Morteza Mahmoudi8333426229
Network Information
Related Institutions (5)
Mashhad University of Medical Sciences
18.7K papers, 252.5K citations

97% related

Isfahan University of Medical Sciences
19.5K papers, 248.6K citations

95% related

Tarbiat Modares University
32.6K papers, 526.3K citations

89% related

Shahid Beheshti University
21K papers, 293.7K citations

88% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023105
2022525
20216,042
20206,181
20195,322
20184,885